商品名称：AdnaTest ProstateCancerPanel AR-V7
The AdnaTest ProstateCancerSelect is used for the enrichment of CTCs from whole blood in prostate cancer research. Subsequently, the AdnaTest ProstateCancerPanel AR-V7 is used for molecular characterization by analyzing gene expression of AR-V7 and further prostate cancer associated genes. In spiking experiments, 2 tumor cells in 5 ml of whole blood are detected at a recovery rate of 95%. >
| Recovery [%] | n | |
|---|---|---|
| 2 tumor cells spiked into 5 ml blood | 38/40 (95%) | 40 |
Two cancer cells (Prostate cancer cell line LnCap) were spiked into blood samples (5 ml) from healthy donors (n=40) to determine the recovery rates achieved with the AdnaTest ProstateCancerPanel AR-V7 as summarized in above. >
Fourteen male healthy donors were analyzed with the AdnaTest ProstateCancerPanel AR-V7 to determine the rate of false positives/specificity at the given cut offs. >
| PSA | PSMA | ARwt | AR-V7 | |
|---|---|---|---|---|
| Cut-off | 35.00 | 35.00 | 35.00 | 35.00 |
| Positives after cut-off | 0 | 0 | 1 | 0 |
| Specificity | 100% | 100% | 93% | 100% |
The AdnaTest ProstateCancerPanel AR-V7 could demonstrate in this performance evaluation a specificity of 100% for all tumor associated genes (PSA, PSMA, AR-V7) except ARwt where it reached 93% (details in table above). Also, GAPDH reached 100% specificity and CD45 79%, respectively, whereas these 2 genes are not used for CTC characterization as such, hence a specificity below 90% for those two target genes is acceptable. >
Perfect linearity and efficiency of the qRT-PCR reactions for each of the genes contained in the AdnaTest ProstateCancerPanel AR-V7 was proven in a serial dilution series of standards (See “AR-V7 Panel gene dilutions”). The positive control has been used as template for standard sample generation.
The resulting Ct values for this dilution series were clearly linear, correlated to the copy numbers for each gene at each dilution step (See “AR-V7 Panel gene dilutions”) getting down to ~500 copies. The qRT-PCR efficiency of all the tumor cell related genes was higher than 90% and the corresponding amplification factors ranged above 1.9 which all in all can be taken as a prove for very effective and sensitive qRT-PCR design (see the table below).>
| PSA | PSMA | AR | AR-V7 | |
|---|---|---|---|---|
| Slope over the range | -3.55 | -3.58 | -3.56 | -3.48 |
| Efficiency: -1+10(-1/slope) | 91% | 90% | 91% | 94% |
| Amplification factor: 10^(1/-slope) | 1.91 | 1.90 | 1.91 | 1.94 |
The AdnaTest ProstateCancerPanel AR-V7 workflow was tested in 12 castration-resistant prostate cancer (CRPC) samples. See "Gene profile in clinical samples.">
Copyright © 2016-2025 汇佰生物科技（深圳）有限公司 版权所有 保留一切权利 备案号 粤ICP备2022123097号-1 
粤公网安备 44031102000815号
